2028년까지 아시아 태평양 의료 규제 업무 아웃소싱 시장 예측 – 서비스 유형별 코로나19 영향 및 지역 분석(규제 및 과학 전략 개발, 의료 및 과학 글쓰기, eCTD 및 전자 제출, 데이터 관리 서비스, 수명 주기 관리 서비스, 약물 감시, 화학 제조 및 제어(CMC) 서비스, 규제 라벨링 및 규제 삽화 서비스) 및 최종 사용자(제약 회사, 생명 공학 회사 및 의료 기기 회사)
시장 소개
아시아 태평양은 중국, 일본, 인도, 호주, 그리고 한국. 시장은 아시아 태평양 지역의 나머지 국가에 대해서도 평가됩니다. 시장은 상대적으로 저렴한 아웃소싱 비용, 기술 전문 지식을 갖춘 숙련된 인력, 인도 및 중국과 같은 국가의 의료 회사 확장과 같은 요인에 의해 주도됩니다. 또한 인도, 동남아시아, 중국과 같은 신흥 경제국 시장에 진출하려는 임상 시험 수가 증가하고 기업 수가 증가하면서 예측 기간 동안 의료 규제 업무 아웃소싱 시장 성장에 기여할 것으로 예상됩니다. 일본의 의약품 시장은 기하급수적으로 성장하고 있습니다. 일본의 증가하는 인구 노령화 문제를 해결하기 위해 정부는 규제 정책을 완화하여 신약 개발 및 시장 출시를 가속화하는 데 주력하고 있습니다. 이는 기존 글로벌 제약회사와 신규 진입자가 일본 시장을 개척할 수 있도록 유도할 것으로 예상된다. 이에 따라 Service Type 개발부터 상용화 단계까지 요구되는 다양한 규제 아웃소싱 서비스에 대한 수요가 증가할 것으로 예상됩니다. 비용을 절감하고 서비스 유형 일정을 간소화하기 위해 회사는 주로 규제 및 약물 감시 활동을 업계에 아웃소싱하는 데 중점을 두고 있습니다. 이는 국내 의료 규제 업무 아웃소싱 시장의 성장을 촉진할 것으로 예상됩니다. 전문 치료법, 희귀의약품, 맞춤형 의약품의 발전은 APAC 의료 규제 업무 아웃소싱 시장의 성장을 이끄는 주요 요인입니다.
호조적인 공급 시장과 함께 강력한 존재감 의 글로벌 CRO 및 현지 전문 지식을 갖춘 지역 CRO. 제약 회사는 아시아 태평양 지역을 임상 시험을 수행하기에 매력적인 시장으로 인식하고 있습니다. 그러나 코로나19 팬데믹(세계적 대유행)은 전 세계적으로 전례 없는 어려움을 가져왔습니다. 임상 및 규제 업무, 제조 및 공급망, 이해관계자 참여에 대한 코로나19의 영향으로 인해 끊임없이 성장하는 제약 산업의 속도가 느려졌습니다. 호주는 엄격한 검역 시스템과 첨단 접촉자 추적을 통해 코로나19 확산을 관리하는 조치로 전 세계적으로 높이 평가받고 있습니다. 그러나 일부 현장에서는 감염에 대한 두려움으로 인해 진료소나 병원에 참석하기를 꺼리는 환자/자원봉사자의 임상시험 참여가 감소했습니다. 따라서 팬데믹 상황으로 인해 임상 시험이 중단되고 제품 승인이 지연되며 공급망이 중단되었습니다. 팬데믹으로 인해 제약회사와 규제 기관은 다양한 기능 영역에서 관찰되는 문제를 완화하기 위해 혁신적인 전략을 채택해야 했습니다. 코로나19의 영향으로 여행 금지로 인해 현장 검사가 지연되고 여러 제품에 대한 승인이 지연되었습니다. 이로 인해 약품 활동의 약 65%가 CRO에 아웃소싱되었으며, 향후 그 비율은 75%에 이를 것으로 예상됩니다. 이와 함께 혁신적인 의약품에 대한 수요로 인해 제약회사는 운영 비용을 그대로 유지하면서 신제품을 제공하기 위해 R&D 지출을 늘려야 한다는 압력을 받고 있습니다. 이러한 상황은 또한 의사가 효율적인 방식으로 원격으로 환자를 모니터링할 수 있도록 하는 디지털 플랫폼에 대한 투자를 촉발시켰습니다. 이러한 모든 요소는 아시아 태평양 지역의 의료 규제 업무 아웃소싱 비즈니스에 영향을 미칠 것입니다.
시장 개요 및 역학
APAC의 의료 규제 업무 아웃소싱 시장은 2021년 12억 397만 달러에서 2028년 25억 8687만 달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 11.5%로 성장할 것으로 예상됩니다. 의료 규제 업무 산업은 수백 개의 중소 규모 제한 서비스 제공업체와 소수의 대규모 풀 서비스 다국적 CRO로 매우 세분화되어 있습니다. . 소규모 CRO는 의료 규제 업무 아웃소싱 시장에 진입하는 데 몇 가지 장벽에 직면하는 반면, 지역에 소재한 풀 서비스 CRO는 여러 국가에서 여러 복잡한 규제 서비스를 동시에 관리할 수 있는 능력을 갖춘 필수 인프라를 구축해야 합니다. 나중에는 전략적 파트너와 필수 관계를 구축하고 관련 치료법을 개발하고 고객의 요구 사항을 충족할 수 있는 전문 지식을 개발해야 합니다. 규제 업무 산업 전반에 걸친 통합은 주요 기업이 서비스 제공을 강화하고 시장에서 주요 점유율을 확보하는 데 도움이 되는 새로운 추세입니다. 그러나 이로 인해 광범위한 범위, 광범위한 치료 및 개발 전문 지식, 막대한 자본 및 기술 자원을 갖춘 소수의 대규모 CRO가 생성되어 제약 및 바이오제약 회사의 까다로운 약물 개발 프로그램을 관리할 수 있게 되었습니다.
주요 시장 부문
APAC 의료 규제 업무 아웃소싱 시장은 서비스 유형, 최종 사용자 및 국가를 기준으로 분류되었습니다. 서비스 유형을 기준으로 APAC 의료 규제 업무 아웃소싱 시장은 의료 및 의료 규제 업무 아웃소싱 시장으로 분류됩니다. 과학 저술, 약물 감시, 데이터 관리 서비스, 수명 주기 관리 서비스, eCTD 및 전자 제출, 규제 및 과학 전략 개발, 화학 제조 및 제어(CMC) 서비스, 규제 라벨링 및 규제 삽화 서비스. 의료 & 2020년에는 과학 글쓰기 부문이 시장을 장악했으며 약물 감시 부문은 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다. 최종 사용자를 기준으로 시장은 제약 회사, 생명 공학 회사 및 의료 기기 회사로 분류됩니다. 제약 회사 부문은 2020년 시장을 지배했으며 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다. 마찬가지로, 분류된 의료기기 회사는 의료기기 소재 및 의료기기 소재로 분류됩니다. 생체재료, 의료기기, 바이오마커 및 체외진단(IVD), 의료기기 소프트웨어(SaMD), 의료기기 전기기계, 의료기기 물질 기반, 복합제품의 의료기기
< span>주요 출처 및 나열된 회사
의료에 관한 이 보고서를 준비하는 데 참조된 몇 가지 주요 1차 및 2차 출처 APAC의 규제 업무 아웃소싱 시장에는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사로는 Arriello Ireland Ltd., Azierta Contract Science Support Consulting, IQVIA Inc., PAREXEL INTERNATIONAL CORPORATION, PHARMALEX GMBH, ProductLife Group, ProPharma Group 및 Voisin Consulting Life Sciences(VCLS) 등이 있습니다.
구매 이유 보고서
- APAC 의료 규제 업무 아웃소싱 시장 환경을 이해하고 높은 수익을 보장할 가능성이 가장 높은 시장 부문을 식별합니다
- APAC 의료 규제 업무 아웃소싱 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
- APAC 의료 규제 분야에서 M&A 및 파트너십 거래를 효율적으로 계획하세요. 가장 유망한 예상 판매가 있는 시장 부문을 식별하여 업무 아웃소싱 시장
- APAC 의료 규제 업무 아웃소싱을 통해 다양한 부문의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다. 시장
- 2021~2028년 APAC 지역의 다양한 부문별 시장 수익 예측을 얻으세요.
APAC 의료 규제 업무 아웃소싱 시장 세분화
APAC 의료 규제 업무 아웃소싱 시장 –별 서비스 유형
- 의료 및amp ; 과학 저술
- 약물 감시
- 데이터 관리 서비스
- 수명주기 관리 서비스
- eCTD 및 전자 제출
- 규제 및 과학 전략 개발
- 화학 제조 및 제어(CMC) 서비스
- 규제 라벨링
- 규제 삽화 서비스
APAC 의료 규제 업무 아웃소싱 시장 – 최종 사용자별
- 제약 회사
- 생명공학 회사
- 의료기기 회사
- 의료기기 재료 및amp; 생체재료
- 의료기기 바이오마커 및 체외진단(IVD)
- 의료기기 소프트웨어(SaMD)
- 의료기기 전기기계
- 의료기기 물질 기반
- 복합 제품의 의료 기기
APAC 의료 규제 업무 아웃소싱 시장 - 국가별
- 일본
- 중국
- 인도
- 대한민국
- 호주
- 나머지 APAC
APAC 의료 규제 업무 아웃소싱 시장 -회사 프로필
- Arriello Ireland Ltd.
- Azierta 계약 과학 지원 컨설팅
- IQVIA Inc.
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife 그룹
- ProPharma 그룹
- Voisin Consulting Life Sciences(VCLS)
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Healthcare Regulatory Affairs Outsourcing Market – By Service Type
1.3.2 APAC Healthcare Regulatory Affairs Outsourcing Market – By End User
1.3.3 APAC Healthcare Regulatory Affairs Outsourcing Market – By Country
2. APAC Healthcare Regulatory Affairs Outsourcing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Healthcare Regulatory Affairs Outsourcing Market – Market Landscape
4.1 Overview
4.1.1 Asia Pacific– PEST Analysis
4.2 Expert Opinions
5. APAC Healthcare Regulatory Affairs Outsourcing Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Regulatory Pressure on Healthcare Companies
5.1.2 Escalating Demand for Speedy Approval of New Products
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Advancements in Specialty Therapies, Orphan Drugs, and Personalized Medicines
5.4 Future Trends
5.4.1 Surging Market Consolidation Activities
5.5 Impact Analysis
6. Healthcare Regulatory Affairs Outsourcing Market – APAC Analysis
6.1 APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Forecast and Analysis
7. Healthcare Regulatory Affairs Outsourcing Market Analysis – By Service Type
7.1 Overview
7.2 Healthcare Regulatory Affairs Outsourcing Market, by Service Type (2021 and 2028)
7.3 Regulatory and Scientific Strategy Development
7.3.1 Overview
7.3.2 Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Medical and Scientific Writing
7.4.1 Overview
7.4.2 Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.5 eCTD and E-Submissions
7.5.1 Overview
7.5.2 eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Data Management Services
7.6.1 Overview
7.6.2 Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Life Cycle Management Services
7.7.1 Overview
7.7.2 Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pharmacovigilance
7.8.1 Overview
7.8.2 Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Chemistry Manufacturing and Controls (CMC) Services
7.9.1 Overview
7.9.2 Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Regulatory Labelling
7.10.1 Overview
7.10.2 Regulatory Labelling : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Regulatory Artwork Services
7.11.1 Overview
7.11.2 Regulatory Artwork Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8. APAC Healthcare Regulatory Affairs Outsourcing Market Analysis – By End User
8.1 Overview
8.2 Healthcare Regulatory Affairs Outsourcing Market, by End-User (2020 and 2028)
8.3 Pharmaceutical Companies
8.3.1 Overview
8.3.2 Pharmaceutical Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Biotechnology Companies
8.4.1 Overview
8.4.2 Biotechnology Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Medical Device Companies
8.5.1 Overview
8.5.2 Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Medical Device Software (SaMD) Market
8.5.2.1.1 Overview
8.5.2.1.2 Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.2 Medical Device Materials & Biomaterials Market
8.5.2.2.1 Overview
8.5.2.2.2 Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.3 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market
8.5.2.3.1 Overview
8.5.2.3.2 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.4 Medical Device Electro mechanics Market
8.5.2.4.1 Overview
8.5.2.4.2 Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.5 Medical Device Substance Based Market
8.5.2.5.1 Overview
8.5.2.5.2 Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.6 Medical Device of Combination Product (DDC) Market
8.5.2.6.1 Overview
8.5.2.6.2 Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
9. APAC Healthcare Regulatory Affairs Outsourcing Market – Country Analysis
9.1 Overview
9.1.1 Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
9.1.1.1 China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 China: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.1.3 China: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.1.3.1 China: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.2 Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Japan: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.2.3 Japan: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.2.3.1 Japan: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.3 India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 India: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.3.3 India: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.3.3.1 India: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.4 Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Australia: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.4.3 Australia: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.4.3.1 Australia: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.5 South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 South Korea: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.5.3 South Korea: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.5.3.1 South Korea: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.6 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.6.3 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.6.3.1 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on APAC Healthcare Regulatory Affairs Outsourcing Market
10.1 Overview
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 ProPharma Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Arriello Ireland Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 PAREXEL INTERNATIONAL CORPORATION
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 IQVIA Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PHARMALEX GMBH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ProductLife Group
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Voisin Consulting Life Sciences (VCLS)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Azierta Contract Science Support Consulting
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 4. China: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Healthcare Regulatory Affairs Outsourcing Market, By Service Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Healthcare Regulatory Affairs Outsourcing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 8. India: Healthcare Regulatory Affairs Outsourcing Market, By Service Type– Revenue and Forecast to 2028 (USD Million)
Table 9. India: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 10. India: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 11. Australia: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Australia: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. South Korea: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 21. Inorganic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 22. Glossary of Terms, APAC Healthcare Regulatory Affairs Outsourcing Market
LIST OF FIGURES
Figure 1. APAC Healthcare Regulatory Affairs Outsourcing Market Segmentation
Figure 2. APAC Healthcare Regulatory Affairs Outsourcing Market Segmentation, By Country
Figure 3. APAC Healthcare Regulatory Affairs Outsourcing Market Overview
Figure 4. Medical & Scientific Writing Segment Held the Largest Share of the Service Type Segment in APAC Healthcare Regulatory Affairs Outsourcing Market
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. Asia pacific PEST Analysis
Figure 7. APAC Healthcare Regulatory Affairs Outsourcing Market Impact Analysis of Driver and Restraints
Figure 8. APAC Healthcare Regulatory Affairs Outsourcing Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by Service Type (2020 and 2028)
Figure 10. APAC Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. APAC Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. APAC eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Regulatory Labelling: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Regulatory Artwork Services : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by End-User (2020 and 2028)
Figure 20. APAC Pharmaceutical Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Biotechnology Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. APAC Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. APAC Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. APAC Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. APAC Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. APAC Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. APAC Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Key Country – Revenue (2021) (USD Million)
Figure 30. Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
Figure 31. China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Arriello Ireland Ltd.
- Azierta Contract Science Support Consulting
- IQVIA Inc.
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
- ProPharma Group
- Voisin Consulting Life Sciences (VCLS)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC Healthcare Regulatory Affairs Outsourcing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC Healthcare Regulatory Affairs Outsourcing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the Healthcare Regulatory Affairs Outsourcing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution